Palliative Medicine and Hospice Care · Vol. 3, No. 1 · 2017 · pp. 11–13 · e-ISSN 2377-8393

Parotitis at the End-of-Life

Filipa Tavares Carreiro, Rita Abril, Isabel Galriça Neto

Unidade de Cuidados Continuados e Paliativos, Hospital da Luz, Lisboa, Portugal; Serviço de Medicina Interna, Hospital do Divino Espírito Santo, Ponta Delgada, Portugal Dear Editor, Saliva plays a key role in maintaining physiological homeostasis of the oral cavity and its estimated daily production is of about 500-600 mL /day.
Unidade de Cuidados Continuados e Paliativos, Hospital da Luz, Lisboa, PortugalPortugal

DOI: https://doi.org/10.17140/pmhcoj-3-121 · Published 2017-06-20 · Licence: https://creativecommons.org/licenses/by/4.0 · © 2017 The Author(s)

Also available as PDF (figures and tables appear in the PDF).

Abstract

Saliva plays a key role in maintaining physiological homeostasis of the oral cavity and its estimated daily production is of about 500-600 mL /day. Xerostomia is defined as the subjective feeling of dry mouth caused either by changes in the saliva consistency, or by the acute reduction of its production, by 50% or more.

Acknowledgements

tionally, comparing to previous publications, the mortality rate was higher in this case series. This is probably due to our short All authors contributed equally to the work.

sample but reveals the parotitis poor prognosis. The multiple comorbidities had a negative impact, contributing to the onset of

Conflicts Of Interest

parotitis and to a short-term adverse outcome. Also, note that the prescribed antibiotherapy does not linearly favor the resolution The authors declare that they have no conflicts of interest. of the clinical situation.

References

  1. CoutazMMorisodJ. Parotidite bacteriénne aigue chez le this topic, but it is estimated that the mortality rate reaches about sujet âgé [In French]. Rev Med Suisse. 2009; 5: e1942-e1945; 50% after its diagnosis.3 Parotitis is a marker of poor prognosis, directly related to the principal diagnosis and to the associated
  2. Eijk J, Campen J, van der Jagt H, Beijnen JH, Tulner LR. comorbidities, which affect the patients’ vulnerability to the use Prevalence of xerostomia and its relationship with underlyof drugs directly responsible for xerostomia. ing diseases, medication and nutrition: A descriptive observational study. J Am Geriatr Soc. 2013; 61(10): e1836-1837. doi: There are certain measures that help preventing xero- 10.1111/jgs.12469 stomia and, thus, the emergence of parotitis, such as the use of substances increasing salivary secretion, the optimization of oral https://doi.org/10.1111/jgs.12469
  3. Desoutter A, Soudan-Pineau M, Munsch F, Mauprivez C, Duhygiene, the lubrication of the oral mucosa, and the local applicafour T, Coeuriot JL. Xerostomia and medication: A cross-sectional study in long-term Geriatric Wards. J Nutr Health Aging. e370. doi: 10.1016/j.jamda.2014.01.014 2012; 16(6): 575-579. doi: 10.1007/s12603-012-0007-2 5. Chambers J. Bacterial Parotitis secondary to antisecretory https://doi.org/10.1016/j.jamda.2014.01.014
  4. CoutazM. Acute bacterial parotitis in the frail eldery subject: medication. Palliat Med. 2008; 22: 394. doi: 10.1177/026921 A Harbinger of death? J Am Med Dir Assoc. 2014; 15: e369- 630708732110.1177/026921 https://doi.org/10.1177/026921